INTRODUCTION:

The monkeypox virus (MPXV) belongs to the Orthopoxvirus genus, which also includes the variola virus (the causative agent of smallpox), cowpox virus, and vaccinia virus¹. Understanding the structure of MPXV is crucial for developing diagnostic tools, treatments, and vaccines.

1. Virion Structure:

MPXV is a large, complex, double-stranded DNA virus with a size of approximately 200-250 nanometres. The virus has a brick-shaped or ovoid structure, similar to other orthopoxviruses. The outer membrane of the virus is derived from the host cell's plasma membrane during viral budding, which helps in immune evasion².

Figure 1. Virion Structure of MPXV

2. Genomic Characteristics:

The MPXV genome is about 196,000 base pairs long and encodes around 190 genes. These genes are responsible for the virus's ability to replicate within host cells, modulate the host immune response, and facilitate viral assembly and egress. The genome is divided into a central conserved region flanked by variable regions that contain genes related to virulence and host range³.

Figure 2. Structure of MPXV Genome

3. Key Proteins:

The viral envelope contains several glycoproteins essential for the virus's attachment to and entry into host cells. Notable among these are the hemagglutinin (HA) protein and a set of fusion proteins that mediate membrane fusion during viral entry. These proteins are potential targets for vaccines and antiviral drugs⁴.

TYPES OF MONKEYPOX VIRUS:

Monkeypox is categorized into two distinct clades based on geographical distribution and genetic differences: the Central African (Congo Basin) clade and the West African clade.

1. Central African Clade:

Also known as the Congo Basin clade, this variant is associated with more severe disease and a higher case fatality rate, which can range between 3% to 10%. This clade has a history of causing more significant human-to-human transmission, leading to larger outbreaks⁵.

2. West African Clade:

This clade is generally associated with a milder form of the disease and a lower-case fatality rate, typically less than 1%. The West African clade is less transmissible than the Central African clade, but recent outbreaks outside Africa have primarily involved this variant⁶.

SYMPTOMS OF MONKEYPOX:

The clinical manifestation of monkeypox can vary from mild to severe, and understanding the typical symptoms is crucial for early detection and management.

1. Incubation Period:

The incubation period for monkeypox typically ranges from 5 to 21 days, with most cases presenting symptoms within 7 to 14 days after exposure.

2. Initial Symptoms (Prodromal Phase):

The disease often begins with non-specific symptoms such as fever, intense headache, myalgia (muscle pain), back pain, and asthenia (profound weakness). A key distinguishing feature of monkeypox from smallpox and chickenpox is the presence of lymphadenopathy (swelling of the lymph nodes), particularly in the neck, armpits, and groin areas².

3. Rash Development:

The hallmark of monkeypox is the characteristic rash, which typically appears 1 to 3 days after the onset of fever. The rash progresses through several stages:

· Macules: Flat, discolored spots on the skin.

· Papules: Raised lesions.

· Vesicles: Fluid-filled blisters that develop from the papules.

· Pustules: Pus-filled lesions that can be painful.

· Scabs: Crusts that form as pustules dry up and heal.

The rash often begins on the face before spreading to other body parts, including the palms, soles, and mucous membranes. Lesions may be found on the genitals and the perianal region, particularly in recent outbreaks⁵.

4. Duration:

The illness typically lasts for 2 to 4 weeks. While most patients recover without treatment, the disease can cause complications such as secondary bacterial infections, respiratory distress, and, in severe cases, encephalitis.

DIAGNOSIS OF MONKEYPOX:

Given the resurgence of monkeypox, accurate and timely diagnosis is essential for controlling outbreaks and providing appropriate care.

1. Clinical Diagnosis:

Healthcare providers often begin with a clinical diagnosis based on the patient's symptoms, travel history to endemic areas, and potential exposure to infected animals or individuals. However, clinical diagnosis alone can be challenging due to the similarity of symptoms with other pox-like diseases, such as chickenpox and smallpox⁶.

2. Laboratory Diagnosis:

· Polymerase Chain Reaction (PCR): PCR is the gold standard for diagnosing monkeypox. It involves detecting the DNA of the monkeypox virus in samples taken from skin lesions, blood, or oropharyngeal swabs. This method is highly specific and sensitive, allowing for the differentiation between the two clades of the virus⁷.

· Serology: Serological tests can detect antibodies against the monkeypox virus, indicating either a current or past infection. However, these tests are less reliable during the early stages of the disease(8).

· Virus Isolation: The virus can be isolated from clinical samples and grown in cell culture, though this method is primarily used in research settings due to the need for specialized facilities.

3. Differential Diagnosis:

Monkeypox must be differentiated from other conditions that cause similar symptoms, such as smallpox, chickenpox, measles, bacterial skin infections, and allergic reactions.

TREATMENT OF MONKEYPOX:

Currently, there is no specific treatment approved exclusively for monkeypox. However, several strategies have been employed to manage and alleviate the symptoms of the disease.

1. Supportive Care:

The primary treatment for monkeypox is supportive care, which includes ensuring adequate hydration, managing fever and pain, and treating any secondary bacterial infections that may occur. Patients with severe disease may require more intensive care, including respiratory support if needed.

2. Antiviral Therapies:

· Tecovirimat (TPOXX): Tecovirimat, an antiviral medication initially developed for smallpox, is effective against orthopoxviruses, including monkeypox. It works by inhibiting the viral protein required for viral egress, thereby preventing the virus from spreading within the body. In 2022, the U.S. Food and Drug Administration (FDA) expanded the use of tecovirimat under compassionate use protocols for monkeypox treatment⁹.

· Cidofovir: This antiviral is another option that has been used to treat severe cases of monkeypox, though its use is limited by potential nephrotoxicity¹⁰.

· Brincidofovir: A newer antiviral with a better safety profile than cidofovir, brincidofovir has been investigated as a treatment for orthopoxvirus infections, including monkeypox¹⁰.

3. Vaccination:

The smallpox vaccine (ACAM2000) and the newer, non-replicating smallpox and monkeypox vaccine (JYNNEOS, also known as Imvamune or Imvanex) have been employed in both pre-and post-exposure prophylaxis. The use of these vaccines, particularly JYNNEOS, has been expanded in response to the 2022 outbreak to protect high-risk populations, including healthcare workers and close contacts of confirmed cases¹¹.

PREVENTIVE MEASURES AND PRECAUTIONS:

Preventing the spread of monkeypox requires a comprehensive approach that includes both public health measures and individual precautions.

1. Isolation and Quarantine:

Patients diagnosed with monkeypox should be isolated to prevent transmission to others. In recent outbreaks, isolation protocols have been critical in controlling the spread, particularly in non-endemic regions. Close contacts should be monitored for symptoms and may be quarantined if necessary.

2. Personal Protective Equipment (PPE):

Healthcare workers and caregivers should use appropriate PPE, including gloves, masks, gowns, and eye protection when caring for patients with suspected or confirmed monkeypox. This is particularly important in preventing nosocomial (hospital-acquired) infections.

3. Hygiene and Sanitation:

Regular hand hygiene, including washing with soap and water or using alcohol-based hand sanitizers, is essential to prevent the spread of the virus. Disinfecting surfaces and objects that may be contaminated with the virus also play a crucial role in limiting transmission.

4. Vaccination Campaigns:

In response to the recent outbreaks, vaccination campaigns have been ramped up, especially in affected regions. The JYNNEOS vaccine has been deployed in various countries to protect high-risk groups. The vaccine has also been used in a "ring vaccination" strategy, where close contacts of confirmed cases are vaccinated to prevent further spread^11,12.

5. Public Awareness and Education:

Public health authorities have emphasized the importance of educating the public about monkeypox, its transmission, symptoms, and preventive measures. In the 2022 outbreak, misinformation and stigma were identified as significant challenges, underscoring the need for clear and accurate communication¹³.

IMPACT OF MONKEYPOX ON GLOBAL HEALTH:

The recent monkeypox outbreaks have had far-reaching consequences beyond the immediate health effects, impacting various aspects of society, the economy, and public health infrastructures globally. Understanding these impacts is essential for framing the response to this re-emerging zoonotic threat.

1. Public Health Impact:

The global public health impact of monkeypox has been profound, especially in the context of the COVID-19 pandemic, which has already stretched healthcare resources. The re-emergence of monkeypox has highlighted vulnerabilities in global health systems, particularly in terms of surveillance, preparedness, and response capabilities.

· The strain on Healthcare Systems: In regions where monkeypox outbreaks have occurred, healthcare facilities have faced additional pressure. The need for isolation wards, PPE, and increased testing capacity has stretched resources, particularly in under-resourced areas. In some cases, routine medical services have been disrupted as healthcare workers are diverted to manage the outbreak¹⁴.

· Surveillance and Response Challenges: The resurgence of monkeypox in non-endemic countries has revealed gaps in global disease surveillance systems. Many countries were unprepared for the rapid spread of the virus, leading to delays in diagnosis and containment efforts. The outbreaks have underscored the importance of robust surveillance systems that can quickly detect and respond to emerging infectious diseases¹⁵.

· Cross-border Transmission: The international spread of monkeypox has demonstrated the ease with which infectious diseases can cross borders, particularly in a highly interconnected world. The movement of people, animals, and goods has facilitated the spread of the virus to non-endemic regions, complicating containment efforts¹⁶.

2. Economic Impact:

The economic consequences of monkeypox outbreaks are multifaceted, affecting both healthcare costs and broader economic activities.

· Healthcare Costs: The direct costs associated with diagnosing, treating, and containing monkeypox are substantial. These include the costs of medical care, isolation facilities, contact tracing, and vaccination campaigns. In addition, the need to implement public health measures such as quarantine can lead to lost productivity and increased healthcare expenditures¹⁵.

· Impact on Travel and Trade: Monkeypox outbreaks have led to travel restrictions and advisories in affected regions, impacting tourism and international trade. Countries experiencing outbreaks may face economic losses due to decreased travel and trade activities, as well as the costs associated with implementing and enforcing travel restrictions¹⁷.

· Business Disruptions: In regions affected by monkeypox, businesses may experience disruptions due to workforce shortages caused by illness, quarantine, or care responsibilities. Additionally, the psychological impact of the outbreak may lead to changes in consumer behavior, further affecting local economies¹⁸.

3. Social and Psychological Impact:

The social and psychological effects of monkeypox outbreaks are significant, contributing to fear, stigma, and mental health challenges.

· Fear and Stigma: The visible symptoms of monkeypox, particularly the characteristic rash, can lead to fear and stigma among affected individuals and communities. In some cases, this stigma can result in social isolation, discrimination, and reluctance to seek medical care, which can exacerbate the spread of the virus¹³.

· Mental Health Challenges: The fear of contracting monkeypox, combined with the stress of isolation and the impact of stigma, can contribute to mental health challenges. Individuals who contract the virus or are in quarantine may experience anxiety, depression, and other psychological issues. The broader community may also experience heightened levels of fear and anxiety, particularly in areas where the virus is spreading¹⁸.

· Community Trust and Public Health Messaging:

Public health efforts to control monkeypox require effective communication and community engagement. However, misinformation and distrust in public health authorities can hinder these efforts. In some cases, communities may resist public health measures due to fear or misunderstanding, making it more difficult to contain the outbreak¹⁷.

4. Global Health Security:

The resurgence of monkeypox has significant implications for global health security, underscoring the need for international collaboration and preparedness.

· Emerging Infectious Diseases: Monkeypox is a reminder of the ongoing threat posed by emerging infectious diseases. The virus's ability to cross species barriers and spread to new regions highlights the importance of a "One Health" approach that considers the interconnectedness of human, animal, and environmental health¹⁴.

· Vaccine Development and Distribution: The monkeypox outbreaks have accelerated efforts to develop and distribute vaccines. The availability of effective vaccines, such as JYNNEOS, has been crucial in controlling the spread of the virus. However, challenges remain in ensuring equitable access to vaccines, particularly in low- and middle-income countries¹¹.

· International Collaboration: The global response to monkeypox has emphasized the importance of international collaboration in addressing public health threats. Organizations such as the World Health Organization (WHO) have played a critical role in coordinating the response, providing guidance, and supporting affected countries. However, the outbreaks have also highlighted the need for stronger global health governance and funding to prepare for and respond to future pandemics¹.

RECENT DEVELOPMENTS AND FUTURE DIRECTIONS:

The 2022 monkeypox outbreak marked a turning point in the global understanding and management of the virus. As of mid-2024, several important developments have shaped the response to the ongoing outbreaks and informed future strategies.

1. Expanded Surveillance and Reporting:

In response to the outbreaks, many countries have enhanced their surveillance systems to detect and report monkeypox cases more rapidly. This has included increased testing capacity, improved diagnostic tools, and better data sharing between countries. The WHO has also updated its guidelines for surveillance, including the criteria for reporting suspected cases¹.

2. New Vaccination Strategies:

The use of ring vaccination (vaccinating close contacts of confirmed cases) has been a key strategy in controlling the spread of monkeypox. Additionally, some countries have implemented broader vaccination campaigns targeting high-risk populations, such as healthcare workers, men who have sex with men (MSM), and individuals with compromised immune systems¹¹.

3. Research and Development:

Ongoing research into monkeypox has focused on understanding the virus's transmission dynamics, identifying new therapeutic options, and improving vaccine efficacy. The development of second-generation vaccines that offer longer-lasting protection and fewer side effects is a priority. Researchers are also exploring the potential for antiviral drugs like tecovirimat to be used more widely in the treatment of monkeypox⁷.

4. Public Health Preparedness:

The monkeypox outbreaks have prompted many countries to reassess their public health preparedness plans. This includes strengthening healthcare infrastructure, improving access to vaccines and treatments, and ensuring that public health messaging is clear, accurate, and culturally sensitive. The outbreaks have also highlighted the importance of maintaining stockpiles of vaccines and antivirals that can be deployed quickly in response to emerging threats¹⁷.

5. Global Health Governance:

The international response to monkeypox has raised important questions about global health governance. There is a growing recognition that the world needs more robust mechanisms for coordinating responses to emerging infectious diseases. This includes ensuring that resources are allocated equitably and that all countries can detect and respond to outbreaks. The role of the WHO in leading global health efforts has been reaffirmed, but there is also a push for reforms to make the organization more effective and responsive to future health crises¹⁴.

CONCLUSION:

The monkeypox outbreak of recent years has underscored the importance of vigilance, preparedness, and international cooperation in addressing emerging infectious diseases. While the virus was once thought to be confined to remote regions of Africa, its spread to non-endemic areas has highlighted the need for a global approach to public health.

Understanding the structure, symptoms, diagnosis, treatment, and prevention of monkeypox is critical for managing the disease and mitigating its impact on individuals and communities. The recent outbreaks have spurred advances in vaccine development, diagnostics, and treatment options, but challenges remain in ensuring that these tools are accessible to all who need them.

As the world continues to grapple with the ongoing challenges posed by monkeypox and other emerging pathogens, the lessons learned from these outbreaks will be crucial in shaping future public health strategies. By strengthening surveillance, improving access to vaccines and treatments, and fostering international collaboration, the global community can better prepare for and respond to the threats posed by infectious diseases like monkeypox.

The response to monkeypox is a reminder of the importance of global solidarity in the face of public health challenges. As new outbreaks emerge, the world must remain vigilant and committed to protecting the health and well-being of all people, regardless of where they live.

REFERENCES:

1. Monkeypox Fact Sheet. World Health Organization (WHO). [Online] August 26, 2024. [Cited: September 02, 2024.] https://www.who.int/news-room/fact-sheets/detail/monkeypox.

2. IK, McCollum AM, Damon. Human Monkeypox. S.L. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America, 2014; 58: 260-267.

3. Genomic Variability of monkeypox virus among humans, Democratic Republic of the Congo. Kugelman, J. R., Johnston, S. C., Mulembakani, P. M., Kisalu, N., Lee, M. S., Koroleva, G., McCarthy, S. E., Gestole, M. C., Wolfe, N. D., Fair, J. N., Schneider, B. S., Wright, L. L., Huggins, J., Whitehouse, C. A., Wemakoy, E. O., Muyembe-Tamfum, J. J. Emerging infectious diseases. 2014; 20: 232–239.

4. A tale of two clades: monkeypox viruses. Likos, A. M., Sammons, S. A., Olson, V. A., Frace, A. M., Li, Y., Olsen-Rasmussen, M., Davidson, W., Galloway, R., Khristova, M. L., Reynolds, M. G., Zhao, H., Carroll, D. S., Curns, A., Formenty, P., Esposito, J. J., Regnery, R. L., Damon, I. K. 10, , The Journal of General Virology. 2005; 86: 2661–2672.

6. Clinical manifestations of human monkeypox influenced by route of infection. Reynolds, M. G., Yorita, K. L., Kuehnert, M. J., Davidson, W. B., Huhn, G. D., Holman, R. C., and Damon, I. K. The Journal of Infectious Diseases. 2006; 194: 773–780.

7. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Hutin, Y. J., Williams, R. J., Malfait, P., Pebody, R., Loparev, V. N., Ropp, S. L., Rodriguez, M., Knight, J. C., Tshioko, F. K., Khan, A. S., Szczeniowski, M. V., and Esposito, J. J. Emerging Infectious Diseases. 2001; 7: 434–438.

8. Monkeypox virus detection in rodents using real-time 3'-minor groove binder TaqMan assays on the Roche LightCycler. Kulesh DA, Loveless BM, Norwood D, Garrison J, Whitehouse CA, Hartmann C, Mucker E, Miller D, Wasieloski LP Jr, Huggins J, Huhn G, Miser LL, Imig C, Martinez M, Larsen T, Rossi CA, Ludwig GV. Lab Invest. 2004; 84: 1200-1208.

9. A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Parker S, Buller RM. Future Virol. 2013; 8: 129-157.

10. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Adler H, Gould S, Hine P, et al. The Lancet. Infectious diseases. 2022; 22: 1153–1162.

11. Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus. Smith SK, Self J, Weiss S, et al. Journal of virology, 2011; 85: 9176–9187.

12. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. Lederman ER, Davidson W, Groff HL, et al. The Journal of Infectious Diseases. 2012; 206: 1372–1385.

13. Construction of Peptide Vaccine Candidate Based on β-Cell Epitopes of Indonesian Monkeypox Virus (MPXV) Virulence Protein: A Reverse Vaccinology. Viol Dhea Kharisma, A. N. M. Ansori, Ahmad Affan Ali Murtadlo, Muhammad Hermawan Widyananda, Emdad Ullah, Sin War Naw, Vikash Jakhmola, Kiran Dobhal, Tarun Parashar, Maksim Rebezov, Rahadian Zainul. Research Journal of Pharmacy and Technology. 2024; 17.

14. Stigma and Discrimination During COVID-19 Pandemic. Bhanot D, Singh T, Verma SK, Sharad S., Frontiers in Public Health. 2021; 8.

15. What is a resilient health system? Lessons from Ebola. Kruk ME, Myers M, Varpilah ST, Dahn BT. 9980. Lancet. 2015; 385: 1910–1912.

16. Community engagement for health system resilience: evidence from Liberia's Ebola epidemic. Barker KM, Ling EJ, Fallah M, et al. Health Policy Plan. 2020; 35: 416-423.

17. Smallpox: emergence, global spread, and eradication. F., Fenner. 3. History and Philosophy of the Life Sciences. 1993; 15: 397–420.

18. The One Health Concept: 10 Years Old and a Long Road Ahead. Destoumieux-Garzón D, Mavingui P, Boetsch G, et al. Frontiers in veterinary science. 2018; 5.

19. The Impact of Epidemics and Pandemics on the Mental Health of Healthcare Workers: A Systematic Review. Chigwedere OC, Sadath A, Kabir Z, Arensman E. International Journal of Environmental Research and Public Health. 2021; 18.